Controversial biotech firm Organovo (ONVO) will conduct an online conference for investors on April 10 at 12:00 pm ET. CEO Keith Murphy will provide an update on the firm's liver tox assay, breast cancer model, R&D and cash position.
Shares have been under pressure since hitting a peak of $13.65 on November 18. Yesterday's close was $7.24.
The company plans to launch its first product, the liver toxicity assay, later this year.